BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20043463)

  • 1. Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
    Argiris A; Gadgeel SM; Dacic S
    Oncology (Williston Park); 2009 Nov; 23(13):1147-8, 1150. PubMed ID: 20043463
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
    Sandler AB
    Oncology (Williston Park); 2006 May; 20(6):626-8. PubMed ID: 16773846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-small-cell bronchial cancers at stage III. Therapeutic strategy].
    Sculier JP; Quoix E
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):319-22. PubMed ID: 9690301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-small-cell lung cancer.
    Mulshine JL; Glatstein E; Ruckdeschel JC
    J Clin Oncol; 1986 Nov; 4(11):1704-15. PubMed ID: 2430072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the treatment of metastatic non-small-cell lung cancer: slow but steady!
    Ramnath N; Govindan R
    Clin Lung Cancer; 2009 Jul; 10(4):260-1. PubMed ID: 19632945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?].
    Pérol M
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S20-7. PubMed ID: 15211228
    [No Abstract]   [Full Text] [Related]  

  • 8. How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
    Kunitoh H; Suzuki K
    Br J Cancer; 2007 May; 96(10):1498-503. PubMed ID: 17473830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic pulmonary cytology: why all the fuss over "NSCLC"?
    Cohen MB; Weydert JA
    Cancer Cytopathol; 2011 Feb; 119(1):3-4. PubMed ID: 21319309
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues at the cutting edge in stage III non-small-cell lung cancer.
    Green MR; Lilenbaum RC
    Ann Oncol; 1995; 6 Suppl 3():S33-6. PubMed ID: 8616112
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy tripleheader extends life for non-small cell lung cancer patients. Concurrent radiation, chemotherapy and lobectomy increase survival for those with NSCLC.
    Health News; 2005 Oct; 11(10):5-6. PubMed ID: 16250091
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of non-small cell lung cancer patients with performance status2 (PS2).
    Boukovinas I; Kosmidis P
    Lung Cancer; 2009 Jan; 63(1):10-5. PubMed ID: 18586349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 15. [New developments in treatment of non-small cell lung cancer].
    Reinmuth N; Gröschel A; Reck M
    Pneumologie; 2013 Nov; 67(11):634-8. PubMed ID: 24198238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal survival after chemoradiation therapy for "non-bulky" stage IIIA NSCLC: what are the implications?
    Grannis FW
    Ann Thorac Surg; 2009 Apr; 87(4):1320; author reply 1320-1. PubMed ID: 19324191
    [No Abstract]   [Full Text] [Related]  

  • 18. Thoracic Oncology: Current Standard Therapy and Future Developments.
    Stinchcombe TE; Bradley JD
    J Clin Oncol; 2022 Feb; 40(6):527-529. PubMed ID: 34985922
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):320-32. PubMed ID: 9230769
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
    Langer CJ; Wakelee H; Schiller J; Choy H; Shepherd F; Vokes EE; Adjei AA; Baas P; Saijo N; Gandara DR
    Clin Lung Cancer; 2008 Mar; 9(2):85-91. PubMed ID: 18501094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.